We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
-0.06%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$60.5B
AUM Growth
+$2.39B
Cap. Flow
+$1.77B
Cap. Flow %
2.93%
Top 10 Hldgs %
17.56%
Holding
4,827
New
882
Increased
1,455
Reduced
1,567
Closed
849

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$210M
2
UNH icon
UnitedHealth
UNH
+$158M
3
NFLX icon
Netflix
NFLX
+$140M
4
DG icon
Dollar General
DG
+$135M
5
MU icon
Micron Technology
MU
+$124M

Sector Composition

Rank Sector Weight
1 Technology 9.07%
2 Consumer Discretionary 6.01%
3 Healthcare 4.63%
4 Industrials 4.29%
5 Financials 4.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZTO icon
3551
ZTO Express
ZTO
$18.3B
$239K ﹤0.01%
11,525
-762,162
-99% -$16.7M
ACH
3552
Accendra Health
ACH
$243M
$239K ﹤0.01%
17,700
-10,706
-38% -$219K
LYG icon
3553
Lloyds Banking Group
LYG
$89B
$238K ﹤0.01%
87,077
-414,981
-83% -$1.11M
EVBN
3554
DELISTED
Evans Bancorp Inc
EVBN
$237K ﹤0.01%
+8,430
New +$227K
BMEA icon
3555
Biomea Fusion
BMEA
$92.5M
$237K ﹤0.01%
+52,628
New +$535K
BBWI icon
3556
Bath & Body Works
BBWI
$4.16B
$237K ﹤0.01%
6,061
-249,013
-98% -$11.4M
KE
3557
Kimball Electronics
KE
$600M
$237K ﹤0.01%
+10,766
New +$235K
RAMP icon
3558
LiveRamp
RAMP
$2.3B
$236K ﹤0.01%
7,621
+1,637
+27% +$52.6K
ATLC icon
3559
Atlanticus Holdings
ATLC
$1.52B
$234K ﹤0.01%
8,310
+704
+9% +$18.8K
KOP icon
3560
Koppers
KOP
$959M
$233K ﹤0.01%
+6,312
New +$294K
CZR icon
3561
Caesars Entertainment
CZR
$6.11B
$233K ﹤0.01%
5,865
-309,017
-98% -$11.6M
UEIC icon
3562
Universal Electronics
UEIC
$57.2M
$233K ﹤0.01%
20,033
-13,248
-40% -$149K
PBYI icon
3563
Puma Biotechnology
PBYI
$409M
$233K ﹤0.01%
71,391
+10,757
+18% +$47.2K
OKLO
3564
Oklo
OKLO
$7.13B
$232K ﹤0.01%
27,431
+12,028
+78% +$135K
CPSS icon
3565
Consumer Portfolio Services
CPSS
$201M
$232K ﹤0.01%
23,677
+1,197
+5% +$10.2K
INTR icon
3566
Inter&Co
INTR
$2.4B
$232K ﹤0.01%
37,708
+11,949
+46% +$68.8K
OTLK icon
3567
Outlook Therapeutics
OTLK
$256M
$232K ﹤0.01%
+31,388
New +$252K
CDXS icon
3568
Codexis
CDXS
$140M
$231K ﹤0.01%
74,531
+39,664
+114% +$127K
NLY icon
3569
PUT
Annaly Capital Management
NLY
$17B
$231K ﹤0.01%
12,100
-76,900
-86% -$1.49M
FLIC
3570
DELISTED
First of Long Island Corp
FLIC
$230K ﹤0.01%
+22,966
New +$233K
SMTC icon
3571
PUT
Semtech
SMTC
$11.7B
$230K ﹤0.01%
+7,700
New +$269K
INFU icon
3572
InfuSystem Holdings
INFU
$187M
$230K ﹤0.01%
+33,659
New +$247K
NBN icon
3573
Northeast Bank
NBN
$1.14B
$229K ﹤0.01%
+3,760
New +$207K
PRSU
3574
Pursuit Attractions and Hospitality Inc
PRSU
$1.46B
$228K ﹤0.01%
+6,710
New +$235K
PAHC icon
3575
Phibro Animal Health
PAHC
$1.41B
$228K ﹤0.01%
13,582
-21,553
-61% -$346K

Similar funds

Squarepoint's Q2 2024 Portfolio in Review

As of Q2 2024, Squarepoint held 4,827 positions worth $60.5B, up 4.1% from $58.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Squarepoint's Q2 2024 filing shows 882 new, 1,455 increased, 1,567 reduced and 849 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,286,013 shares worth $700M. The largest sale was Apple, an estimated $210M.

By sector, the portfolio is most concentrated in Technology at 9.1% of assets, up from 8.5% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Squarepoint's largest Q2 2024 buy was State Street SPDR S&P 500 ETF Trust: 1,286,013 shares worth $700M.
  • Squarepoint added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $1.29B increase.
  • Squarepoint's biggest Q2 2024 reduction was Apple, cutting an estimated $210M.
  • Squarepoint fully exited DraftKings in Q2 2024, selling an estimated $94.6M.
  • Squarepoint's ten largest holdings make up 18% of its $60.5B portfolio in Q2 2024.
  • Squarepoint opened 882 new positions and closed 849 in Q2 2024.
  • Squarepoint's portfolio value rose 4.1% quarter-over-quarter to $60.5B.

Based on Squarepoint's 13F filing for Q2 2024, filed 14 Aug 2024.